Optimal combination secondary prevention drug treatment and stroke outcomes. - Wikidata - wikimedia - TriplyDB

Optimal combination secondary prevention drug treatment and stroke outcomes.

Optimal combination secondary prevention drug treatment and stroke outcomes.

http://www.wikidata.org/entity/Q35106572

about

Association of Optimal Combination Drug Treatment with Obesity Status among Recent Ischemic Stroke Patients: Results of the Vitamin Intervention for Stroke Prevention (VISP) Trial.Optimal combination treatment and vascular outcomes in recent ischemic stroke patients by premorbid risk level Current and Future Treatment Approaches in Transthyretin Familial Amyloid Polyneuropathy.One-year outcomes and secondary prevention in patients after acute minor stroke: results from the China National Stroke Registry.Relationship of functional disability after a recent stroke with recurrent stroke risk.Age and Sex Disparities in Discharge Statin Prescribing in the Stroke Belt: Evidence From the Reasons for Geographic and Racial Differences in Stroke Study.Baseline Prescription and One-Year Persistence of Secondary Prevention Drugs after an index Stroke in Central Ghana.

P2860

Q33783585-62F4D77D-B5D6-461F-B81E-BFE0B5F5D5CA Q35822639-87F9A319-9A13-4114-B0B0-CBEA7AEBBC9D Q38792184-7AC92037-93C0-44C0-A203-8FE2B0894CD2 Q38801855-2F9048D9-75C3-459B-ABC7-E50F0B15BFA3 Q38950763-7905404E-1F7B-452E-9017-D2E6D6292BFA Q40097745-335F5F30-5D07-4E3D-B215-0AE399019394 Q46576530-74C03D33-1228-4334-B3EC-0B3EAC556EF3

P2860

Optimal combination secondary prevention drug treatment and stroke outcomes.

http://www.wikidata.org/entity/Q35106572

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Optimal combination secondary prevention drug treatment and stroke outcomes.

@ast

Optimal combination secondary prevention drug treatment and stroke outcomes.

@en

type

label

Optimal combination secondary prevention drug treatment and stroke outcomes.

@ast

Optimal combination secondary prevention drug treatment and stroke outcomes.

@en

prefLabel

Optimal combination secondary prevention drug treatment and stroke outcomes.

@ast

Optimal combination secondary prevention drug treatment and stroke outcomes.

@en

P1433

Q35106572-1A682068-BE8F-4D04-B238-7636E6F87313

P1476

Q35106572-8BD0ADE7-C6DA-44A5-8CB9-5A2FE16606C4

P2093

Q35106572-BDF0684D-C484-4050-BADD-7AF729B689D4

P2860

Q35106572-1D965D86-9DDF-4775-8B53-FC142B54FA9A

Q35106572-235D868E-C18A-4A04-9D09-1AD31710A5A1

Q35106572-487523B3-2759-413E-B020-D483239C0EA1

Q35106572-48B593C8-1FE9-430B-86CF-2829FCF23197

Q35106572-78EB7ACA-A015-45EA-83E0-6EB49D4D6757

Q35106572-8330DC56-FA5F-4698-AC6D-3A43E8B4A3CC

Q35106572-8DE67F68-0E8D-4C73-9881-697727B8CBD7

Q35106572-8F106220-A62C-426A-AD06-20796C39008C

Q35106572-90531830-ACD0-4F11-B182-97218ABCB795

Q35106572-984D47EF-5C7B-426E-8BAB-A58ACA96EBE4

P304

Q35106572-AC795E3C-BBF2-40D9-B051-848053C28C45

P31

Q35106572-843B6A0D-15A4-4C66-86F4-7F3910DA354C

P356

Q35106572-25D6811F-4CC9-4484-A275-D1E35D231A19

P407

Q35106572-1DEF5938-8BBE-4178-ABEB-D0CC59C6ECEA

P433

Q35106572-620B9D0D-8259-4C8F-8945-433BCAFA05EF

P478

Q35106572-A274BADD-731D-4272-933F-1649F2093799

P50

Q35106572-63523AFB-7DD1-4F69-8F0C-A25A67D19C42

P577

Q35106572-DC8342DC-AEE9-4374-8CB6-EC215B50D656

P698

Q35106572-56B6A98F-B6EE-4304-BADC-05B2BAA992A6

P932

Q35106572-2196971C-7CAF-44E9-B8BD-EAB5581E7347

P356

WNL.0000000000001099

P1433

P1476

Optimal combination secondary prevention drug treatment and stroke outcomes.

@en

P2093

Jong-Ho Park

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

A strategy to reduce cardiovascular disease by more than 80%

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

Combination pharmacotherapy for cardiovascular disease

Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review.

Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry.

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

Impact of combination evidence based medical treatment in patients with acute coronary syndromes in various TIMI risk groups.

Secondary preventive medication persistence and adherence 1 year after stroke

P304

50-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0000000000001099

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P50

Bruce Ovbiagele

P577

2014-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25411440

http://www.w3.org/2001/XMLSchema#string

P932

4336098

http://www.w3.org/2001/XMLSchema#string